semaglutide weight loss clinic rockledge GLP-1 Therapy for in Merritt Island Semaglutide in Chandler AZ -

Cardiovascular outcome trials (SUSTAIN-6) revealed a 26% reduction in major adverse cardiac events, suggesting benefits beyond metabolic control

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (under the brand name Ozempic) and chronic weight management (as Wegovy)

Some people, specifically those who have PCOS, actually see an improvement in their periods after starting a GIP/GLP-1

It is sold under the brand name Ozempic for diabetes management

Reducing overall cholesterol levels Semaglutides primary role as a weight-loss drug indirectly influences cholesterol by reducing overall body fat

Together, these agents help patients feel satisfied with smaller meals, resist snacking impulses, and reduce the emotional or habitual eating patterns that often undermine weight loss efforts